111 related articles for article (PubMed ID: 11046069)
1. Human double-negative T cells in systemic lupus erythematosus provide help for IgG and are restricted by CD1c.
Sieling PA; Porcelli SA; Duong BT; Spada F; Bloom BR; Diamond B; Hahn BH
J Immunol; 2000 Nov; 165(9):5338-44. PubMed ID: 11046069
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic target of rapamycin complex 1 expands Th17 and IL-4+ CD4-CD8- double-negative T cells and contracts regulatory T cells in systemic lupus erythematosus.
Kato H; Perl A
J Immunol; 2014 May; 192(9):4134-44. PubMed ID: 24683191
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic target of rapamycin activation triggers IL-4 production and necrotic death of double-negative T cells in patients with systemic lupus erythematosus.
Lai ZW; Borsuk R; Shadakshari A; Yu J; Dawood M; Garcia R; Francis L; Tily H; Bartos A; Faraone SV; Phillips P; Perl A
J Immunol; 2013 Sep; 191(5):2236-46. PubMed ID: 23913957
[TBL] [Abstract][Full Text] [Related]
4. Type I IFN Drives Experimental Systemic Lupus Erythematosus by Distinct Mechanisms in CD4 T Cells and B Cells.
Klarquist J; Cantrell R; Lehn MA; Lampe K; Hennies CM; Hoebe K; Janssen EM
Immunohorizons; 2020 Mar; 4(3):140-152. PubMed ID: 32161059
[TBL] [Abstract][Full Text] [Related]
5. Elevated apoptosis and impaired proliferation contribute to downregulated peripheral γ δ T cells in patients with systemic lupus erythematosus.
Lu Z; Su D; Wang D; Li X; Feng X; Sun L
Clin Dev Immunol; 2013; 2013():405395. PubMed ID: 24062776
[TBL] [Abstract][Full Text] [Related]
6. Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus.
Jenks SA; Cashman KS; Zumaquero E; Marigorta UM; Patel AV; Wang X; Tomar D; Woodruff MC; Simon Z; Bugrovsky R; Blalock EL; Scharer CD; Tipton CM; Wei C; Lim SS; Petri M; Niewold TB; Anolik JH; Gibson G; Lee FE; Boss JM; Lund FE; Sanz I
Immunity; 2018 Oct; 49(4):725-739.e6. PubMed ID: 30314758
[TBL] [Abstract][Full Text] [Related]
7. Neutralizing anti-IFN-γ IgG was increased in patients with systemic lupus erythematosus and associated with susceptibility to infection.
Chen L; Chi H; Teng J; Meng J; Zhang H; Su Y; Liu H; Ye J; Shi H; Hu Q; Zhou Z; Yang C; Sun Y; Cheng X
Clin Rheumatol; 2024 Jan; 43(1):189-198. PubMed ID: 37857784
[TBL] [Abstract][Full Text] [Related]
8. Potential T Cell-Intrinsic Regulatory Roles for IRF5 via Cytokine Modulation in T Helper Subset Differentiation and Function.
Brune Z; Rice MR; Barnes BJ
Front Immunol; 2020; 11():1143. PubMed ID: 32582209
[TBL] [Abstract][Full Text] [Related]
9. Inactive disease in patients with lupus is linked to autoantibodies to type I interferons that normalize blood IFNα and B cell subsets.
Bradford HF; Haljasmägi L; Menon M; McDonnell TCR; Särekannu K; Vanker M; Peterson P; Wincup C; Abida R; Gonzalez RF; Bondet V; Duffy D; Isenberg DA; Kisand K; Mauri C
Cell Rep Med; 2023 Jan; 4(1):100894. PubMed ID: 36652906
[TBL] [Abstract][Full Text] [Related]
10. IL-4-Induced Quiescence of Resting Naive B Cells Is Disrupted in Systemic Lupus Erythematosus.
Gao M; Liu S; Chatham WW; Mountz JD; Hsu HC
J Immunol; 2022 Oct; 209(8):1513-1522. PubMed ID: 36165181
[TBL] [Abstract][Full Text] [Related]
11. Cytokines in systemic lupus erythematosus.
Lourenço EV; La Cava A
Curr Mol Med; 2009 Apr; 9(3):242-54. PubMed ID: 19355907
[TBL] [Abstract][Full Text] [Related]
12. Expansion of extrafollicular B and T cell subsets in childhood-onset systemic lupus erythematosus.
Baxter RM; Wang CS; Garcia-Perez JE; Kong DS; Coleman BM; Larchenko V; Schuyler RP; Jackson C; Ghosh T; Rudra P; Paul D; Claassen M; Rochford R; Cambier JC; Ghosh D; Cooper JC; Smith MJ; Hsieh EWY
Front Immunol; 2023; 14():1208282. PubMed ID: 37965329
[TBL] [Abstract][Full Text] [Related]
13. The pathology of T cells in systemic lupus erythematosus.
Mak A; Kow NY
J Immunol Res; 2014; 2014():419029. PubMed ID: 24864268
[TBL] [Abstract][Full Text] [Related]
14. B Cell Activation and Plasma Cell Differentiation Are Promoted by IFN-λ in Systemic Lupus Erythematosus.
Barnas JL; Albrecht J; Meednu N; Alzamareh DF; Baker C; McDavid A; Looney RJ; Anolik JH
J Immunol; 2021 Dec; 207(11):2660-2672. PubMed ID: 34706932
[TBL] [Abstract][Full Text] [Related]
15. Neddylation is a novel therapeutic target for lupus by regulating double negative T cell homeostasis.
Zhang Y; Du L; Wang C; Jiang Z; Duan Q; Li Y; Xie Z; He Z; Sun Y; Huang L; Lu L; Wen C
Signal Transduct Target Ther; 2024 Jan; 9(1):18. PubMed ID: 38221551
[TBL] [Abstract][Full Text] [Related]
16. Leptin antagonism attenuates hypertension and renal injury in an experimental model of autoimmune disease.
Kalusche WJ; Case CT; Taylor EB
Clin Sci (Lond); 2023 Dec; 137(23):1771-1785. PubMed ID: 38031726
[TBL] [Abstract][Full Text] [Related]
17. Integration of multi-omics analysis reveals metabolic alterations of B lymphocytes in systemic lupus erythematosus.
Iperi C; Fernández-Ochoa Á; Pers JO; Barturen G; Alarcón-Riquelme M; ; Quirantes-Piné R; Borrás-Linares I; Segura-Carretero A; Cornec D; Bordron A; Jamin C
Clin Immunol; 2024 Jul; 264():110243. PubMed ID: 38735509
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 4-driven reversal of self-reactive B cell anergy contributes to the pathogenesis of systemic lupus erythematosus.
Liu Y; Zhang Z; Kang Z; Zhou XJ; Liu S; Guo S; Jin Q; Li T; Zhou L; Wu X; Wang YN; Lu L; He Y; Li F; Zhang H; Liu Y; Xu H
Ann Rheum Dis; 2023 Nov; 82(11):1444-1454. PubMed ID: 37567607
[TBL] [Abstract][Full Text] [Related]
19. High-frequency and adaptive-like dynamics of human CD1 self-reactive T cells.
de Lalla C; Lepore M; Piccolo FM; Rinaldi A; Scelfo A; Garavaglia C; Mori L; De Libero G; Dellabona P; Casorati G
Eur J Immunol; 2011 Mar; 41(3):602-10. PubMed ID: 21246542
[TBL] [Abstract][Full Text] [Related]
20. Lipid presentation by human CD1 molecules and the diverse T cell populations that respond to them.
Adams EJ
Curr Opin Immunol; 2014 Feb; 26():1-6. PubMed ID: 24556395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
